Bioscience research, including crucial work on COVID-19 treatments, is thriving in the heart of Canada, and the Bioscience Association Manitoba has launched a newsletter to highlight this work.
InnovoXL Inc. is a technology development company that specializes in commercializing promising new technologies that have strong commercial potential. InnovoXL achieves this by providing investment as well as product development and commercialization resources from concept to market.
What makes us unique? It’s our expertise and our approach.
With every prospective endeavour, we perform an exhaustive process of due diligence and we thoroughly analyze every variable that may affect the commercial viability of a venture. If we identify risks that could potentially result in failure of a venture then we will only proceed if we have identified a solution to resolve those risks. As part of our commercialization process we will draw upon our extensive global network of world class experts to assure success of the venture.
Surgical Stabilization Technologies Inc.
Surgical Stabilization Technologies Inc. (SST) is developing and commercializing a novel medical device called the Helix Trocar Stabilization System that will enhance all laparoscopic surgical procedures that utilize trocars. This enhancement will reduce surgery times, surgical trauma and complications resulting in improved patient outcomes.
InnovoXL’s most recent venture is the development and commercialization of the world’s fastest and most advanced food sorting technology. The AdvaSort sorting system is a platform technology that has utility in a broad spectrum of sorting applications including food products such as grains, beans and corn to minerals, pharmaceuticals and manufactured goods.
Rapid Bacteria Detection
InnovoXL is in the process of developing and commercializing the world’s fastest bacteria detection system. Our objective is to selectively determine within an hour instead of days, whether a pathogen is present in a patient’s blood or in drinking water.